Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Total Non-Current Liabilities (2014 - 2026)

Updated

Purple Biotech (PPBT) reported Total Non-Current Liabilities of $170,000 for Q2 2026, up 21.4% from $140,000 a year earlier and up 6.3% from the prior quarter.

Analysis

Purple Biotech (PPBT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Purple Biotech posted Total Non-Current Liabilities of $160,000, up 14.3% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -30.0% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $140,000 in FY2024 (-53.9%), $304,000 in FY2023 (-34.8%), $466,000 in FY2022 (-44.7%) and $842,000 in FY2021 (-11.6%).
  • Five-year quarterly Total Non-Current Liabilities spans a low of $140,000 in Q4 2024 and a high of $842,000 in Q4 2021.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last four quarters, with an average decline of 15.9% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2026 (growth of 21.4%); the low point was Q4 2024 (a decline of 53.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $160,000 (Q1 2026), $160,000 (Q4 2025) and $189,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Purple Biotech 249,214.64 191,214.64 - 170,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170,000.00
Mar 31, 2026 160,000.00
Dec 31, 2025 160,000.00
Sep 30, 2025 189,000.00
Jun 30, 2025 140,000.00
Mar 31, 2025 140,000.00
Dec 31, 2024 140,000.00
Sep 30, 2024 179,000.00
Jun 30, 2024 220,000.00
Mar 31, 2024 262,000.00
Dec 31, 2023 304,000.00
Sep 30, 2023 333,000.00
Jun 30, 2023 378,000.00
Mar 31, 2023 419,000.00
Dec 31, 2022 466,000.00
Sep 30, 2022 501,000.00
Jun 30, 2022 691,000.00
Mar 31, 2022 787,000.00
Dec 31, 2021 842,000.00
Sep 30, 2021 828,000.00
API Access

Purple Biotech Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PPBT&period=max&api_key=YOUR_API_KEY